Clinical Trial Update: A Long Term Study of STN1012600 in Subjects With Open Angle Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

The document reports that the long-term Phase 3 study of STN1012600 in open-angle glaucoma or ocular hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• STN1012600

Snippet

Sponsor: Santen Pharmaceutical Co., Ltd. | Conditions: Open Angle Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED